valine has been researched along with Long QT Syndrome in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imai, S; Inoue, M; Itoh, H; Iwahashi, Y; Osawa, M; Shimada, I; Toyama, Y | 1 |
| Baró, I; Bellocq, C; Boisseau, P; Escande, D; Le Marec, H; Louérat-Oriou, B; Schott, JJ; Wilders, R | 1 |
| Fujiwara, H; Hukunishi, M; Ito, Y; Kakami, M; Kawasaki, M; Matsuno, Y; Minatoguchi, S; Miyajima, K; Nishigaki, K; Takemura, G | 1 |
| Englisch, S; Hesch, RD; Jahr, S; Lewalter, T; Lüderitz, B | 1 |
| Busch, AE; Lerche, C; Scherer, CR; Seebohm, G | 1 |
1 trial(s) available for valine and Long QT Syndrome
| Article | Year |
|---|---|
Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Collagen Type I; Collagen Type III; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Lipid Peroxidation; Long QT Syndrome; Male; Oxidative Stress; Prospective Studies; Tetrazoles; Valine; Valsartan | 2007 |
4 other study(ies) available for valine and Long QT Syndrome
| Article | Year |
|---|---|
Conformational equilibrium shift underlies altered K
Topics: Alanine; Ataxia; Bacterial Proteins; Epilepsy; Humans; Ion Channel Gating; Long QT Syndrome; Magnetic Resonance Spectroscopy; Molecular Dynamics Simulation; Mutation, Missense; Potassium; Potassium Channels; Protein Conformation, alpha-Helical; Recombinant Proteins; Streptomyces lividans; Valine | 2020 |
A common antitussive drug, clobutinol, precipitates the long QT syndrome 2.
Topics: Alanine; Amino Alcohols; Animals; Antitussive Agents; Arrhythmias, Cardiac; Cation Transport Proteins; Chlorocebus aethiops; COS Cells; Electrophysiology; Ether-A-Go-Go Potassium Channels; Humans; Long QT Syndrome; Male; Mutation; Pedigree; Potassium Channels, Voltage-Gated; Proline; Threonine; Valine | 2004 |
New missense mutation (G626V) in the predicted selectivity filter of the HERG channel associated with familial long QT syndrome.
Topics: Cation Transport Proteins; DNA-Binding Proteins; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Glycine; Humans; Long QT Syndrome; Molecular Sequence Data; Mutation, Missense; Potassium Channels; Potassium Channels, Voltage-Gated; Trans-Activators; Transcriptional Regulator ERG; Valine | 2000 |
Identification of specific pore residues mediating KCNQ1 inactivation. A novel mechanism for long QT syndrome.
Topics: Amino Acid Sequence; Animals; Arrhythmias, Cardiac; Electrophysiology; Glycine; Humans; KCNQ Potassium Channels; KCNQ1 Potassium Channel; KCNQ2 Potassium Channel; Long QT Syndrome; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Oocytes; Patch-Clamp Techniques; Point Mutation; Potassium Channels; Potassium Channels, Voltage-Gated; Protein Structure, Tertiary; RNA, Complementary; Sequence Homology, Amino Acid; Time Factors; Valine; Xenopus | 2001 |